Tags

HIV-1 drug

XtalPi AI platform accelerates HIV-1 drug candidate selection within seven months

XtalPi AI platform accelerates HIV-1 drug candidate selection within seven months

September 23, 2026 | 15:35
Technology firm XtalPi utilised artificial intelligence models to nominate a preclinical candidate targeting the MPER region of HIV-1 gp41 for portfolio company Viva-Thera within seven months.

Latest News

Robo.ai shareholders approve all proposed resolutions at extraordinary meeting

Robo.ai shareholders approve all proposed resolutions at extraordinary meeting

XtalPi AI platform accelerates HIV-1 drug candidate selection within seven months

XtalPi AI platform accelerates HIV-1 drug candidate selection within seven months

A-LIGN enters Australian cybersecurity market through AssurePoint acquisition

A-LIGN enters Australian cybersecurity market through AssurePoint acquisition

AirportLabs expands operations management platform into Asian aviation markets

AirportLabs expands operations management platform into Asian aviation markets

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia Ansarada
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society CSR Swing for the Kids
World News
virs-publications-vir
timeout-vn
ptbv2020